Ozempic may help manage opioid addiction: study [Fortune]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Fortune
Patients on semaglutide, the key ingredient in Novo's diabetes drug Ozempic and the weight-loss shot Wegovy, were less than half as likely to overdose as those on insulin, according to the study published Wednesday in JAMA Network Open. Those taking semaglutide were 63% less likely to overdose than those taking DPP-4 inhibitors, a widely used type of diabetes pill. The decrease was remarkable, said Rong Xu , a professor of biomedical informatics at Case Western Reserve University, who led the study. Her team had previously linked semaglutide to a reduction in both alcohol use disorder and smoking . This is the first time a study of this size has looked at opioid overdoses, Xu said. As use of powerful new weight-loss drugs spreads, interest is growing in whether the medicines can blunt not just appetite but also cravings for other substances. While drugmakers have been reluctant to dive into the area, Novo is looking at alcohol consumption in a trial that started this year. The
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Buy These 5 Big Drug Stocks to Boost Your Portfolio's Health [Yahoo! Finance]Yahoo! Finance
- Should You Invest in the Vanguard Health Care ETF (VHT)? [Yahoo! Finance]Yahoo! Finance
- New data show Lilly's EBGLYSS™ (lebrikizumab-lbkz) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitisPR Newswire
- FDA hits Ozempic and Mounjaro counterfeit compounders with warning letters [Yahoo! Finance]Yahoo! Finance
- Lilly's Kisunla™ (donanemab-azbt) Approved in Japan for the Treatment of Early Symptomatic Alzheimer's DiseasePR Newswire
LLY
Earnings
- 8/8/24 - Beat
LLY
Sec Filings
- 9/18/24 - Form 3
- 9/17/24 - Form 4
- 9/17/24 - Form 4
- LLY's page on the SEC website